INTRODUCTION: Peripheral vascular disease (PVD) is a cause of significant morbidity and mortality, which continues to remain a challenging ailment for clinicians. We have recently shown Pellino1 (Peli1) to be a powerful pro-angiogenic molecule downstream of VEGF/Flk-1 signaling. This study attempts to evaluate the role of Peli1 in a murine model of hind limb ischemia (HLI).
METHODS:
Adult 8-12 week old wild-type Peli1fl/fl (WT) and Peli1 knockout (Peli1-/-) mice underwent right femoral artery ligation followed by laser Doppler imaging (LDI), motor function assessment, and muscle immunohistochemistry 28 days after ligation. We further validated our results in a gene therapy model (gain of function) by injecting either Ad.LacZ (control) or Ad.Peli1 (1Â109 PFU) in the hind limb after femoral artery ligation followed by LDI.
RESULTS: Peli1-/-mice showed reduced blood perfusion when compared with WT mice at postoperative day 28 ( 
CONCLUSIONS:
Our results show that Peli1 is a critical molecule in neovascularization in mice with hind limb ischemia. This could translate to a potent therapeutic agent assisting vascular surgeons in treating patients at risk for tissue and limb loss. 
Effects of Pharmacotherapeutic Agents on

INTRODUCTION:
The management of carotid stenosis must balance the benefits of surgical and endovascular intervention against the risks of peri/postoperative cerebrovascular events. Higher rates of intraoperative microembolization during elective carotid revascularization are associated with increased risks of clinically detectable cerebrovascular accidents, and the identification of pharmacotherapeutic agents that prevent vulnerable plaque formation can be useful in decreasing embolic potential during revascularization.
METHODS:
One hundred fifty patients (symptomatic, sten-osis>50%; asymptomatic, stenosis>70%) undergoing either carotid artery stenting or carotid endarterectomy will be enrolled. A preoperative Mini-mental Status Exam (MMSE), carotid MRI, and cerebral diffusion-weighted MRI (DW-MRI) are obtained 1 week before intervention. Intraoperatively, transcranial Doppler is performed to monitor for microembolic signals (MES), detected as high-intensity unidirectional transient signals. A postoperative DW-MRI and MMSE are performed within 72 hours to examine for microinfarcts and changes in neurocognitive function. Analysis of pharmacotherapeutic use is performed retrospectively. 
RESULTS
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